Simplex Trading, LLC Eye Point Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$5.71 - $24.13 $139,609 - $589,978	24,450 New	24,450 $565,000
Q2 2023 Aug 04, 2023	BUY	$3.03 - $9.0 $218 - $648	72 New	72 $0
Q4 2022 Feb 02, 2023	BUY	$2.37 - $7.2 $18,203 - $55,303	7,681 New	7,681 $26,000
Q1 2022 May 02, 2022	SELL	$8.67 - $14.11 $390,982 - $636,304	-45,096 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$10.18 - $18.4 $77,561 - $140,189	7,619 Added 20.33%	45,096 $551,000
Q2 2021 Aug 12, 2021	SELL	$8.69 - $11.08 $67,964 - $86,656	-7,821 Reduced 17.27%	37,477 $336,000
Q1 2021 Apr 26, 2021	BUY	$8.89 - $14.92 $378,838 - $635,800	42,614 Added 1587.7%	45,298 $460,000
Q4 2020 Feb 02, 2021	BUY	$3.7 - $6.58 $9,930 - $17,660	2,684 New	2,684 $17,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.